CRISIL Report on Omkar Speciality Chemicals
Omkar Speciality Chemicals Ltd’s (Omkar’s) Q2FY12 results were largely in line with CRISIL Research estimates. Revenues of Rs 39.20 crore (+37% y-o-y) and EBITDA of Rs 7.70 crore (+42% y-o-y) were in line with CRISIL estimates. However, PAT






























